Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cooper

Showing results (1381-1390 of 1,401) with videos related to

Pageof 141
Sort By:
Thorax|May 9, 2022
COVID-19-related changes in outpatient CPAP setup pathways for OSA are linked with decreased 30-day CPAP usageChris D Turnbull, Martin Allen, Jennifer Appleby, et al.
Annals of the Rheumatic Diseases|April 8, 2017
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeRohit Aggarwal, Lisa G Rider, Nicolino Ruperto, et al.
Annals of the Rheumatic Diseases|September 1, 2017
The EuroMyositis registry: an international collaborative tool to facilitate myositis researchJames B Lilleker, Jiri Vencovsky, Guochun Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2017
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeRohit Aggarwal, Lisa G Rider, Nicolino Ruperto, et al.
Rheumatology (Oxford, England)|October 5, 2017
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspectsLisa G Rider, Nicolino Ruperto, Angela Pistorio, et al.
Annals of the Rheumatic Diseases|January 27, 2017
Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositisJ B Lilleker, A Rietveld, S R Pye, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 14, 2017
Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis SpectrumSimon Rothwell, Robert G Cooper, Ingrid E Lundberg, et al.
Annals of the Rheumatic Diseases|September 13, 2015
Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroupsSimon Rothwell, Robert G Cooper, Ingrid E Lundberg, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 17, 2014
Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparisonJ A McKnight, S H Wild, M J E Lamb, et al.
Annals of the Rheumatic Diseases|May 30, 2019
Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroupsSimon Rothwell, Hector Chinoy, Janine A Lamb, et al.
Pageof 141

Showing results (1381-1390 of 1,401) with videos related to

Sort By:
Pageof 141
Thorax|May 9, 2022
COVID-19-related changes in outpatient CPAP setup pathways for OSA are linked with decreased 30-day CPAP usageChris D Turnbull, Martin Allen, Jennifer Appleby, et al.
Annals of the Rheumatic Diseases|April 8, 2017
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeRohit Aggarwal, Lisa G Rider, Nicolino Ruperto, et al.
Annals of the Rheumatic Diseases|September 1, 2017
The EuroMyositis registry: an international collaborative tool to facilitate myositis researchJames B Lilleker, Jiri Vencovsky, Guochun Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2017
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeRohit Aggarwal, Lisa G Rider, Nicolino Ruperto, et al.
Rheumatology (Oxford, England)|October 5, 2017
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspectsLisa G Rider, Nicolino Ruperto, Angela Pistorio, et al.
Annals of the Rheumatic Diseases|January 27, 2017
Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositisJ B Lilleker, A Rietveld, S R Pye, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 14, 2017
Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis SpectrumSimon Rothwell, Robert G Cooper, Ingrid E Lundberg, et al.
Annals of the Rheumatic Diseases|September 13, 2015
Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroupsSimon Rothwell, Robert G Cooper, Ingrid E Lundberg, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 17, 2014
Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparisonJ A McKnight, S H Wild, M J E Lamb, et al.
Annals of the Rheumatic Diseases|May 30, 2019
Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroupsSimon Rothwell, Hector Chinoy, Janine A Lamb, et al.
Pageof 141